Cognitive dysfunction is increasingly recognized as an important comorbidity of diabetes
mellitus. Different stages of diabetes-associated cognitive dysfunction exist, each with …

Considerable overlap has been identified in the risk factors, comorbidities and putative
pathophysiological mechanisms of Alzheimer disease and related dementias (ADRDs) and …

Recent evidence indicates that sensory and motor changes may precede the cognitive
symptoms of Alzheimer's disease (AD) by several years and may signify increased risk of …

Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than
40 million people worldwide and it is predicted to exponentially increase in the coming …

Abstract Type 2 diabetes (T2D) and its target organ injuries cause distressing impacts on
personal health and put an enormous burden on the healthcare system, and increasing …

Background Insulin resistance is the major pathogenesis underlying type 2 diabetes mellitus
(T2DM) and these patients have doubled risk of Alzheimer's disease (AD). Increasing …

The GLP‐1 receptor agonist exendin‐4 has recently shown good effects in a phase II clinical
trial in Parkinson's disease (PD) patients. Here, a comparison of the new GLP‐1/GIP dual …

Insulin resistance is associated with the occurrence of stroke and atherosclerotic disease.
However, the relationship between insulin resistance and the prognosis of acute ischemic …

Introduction Alzheimer's disease (AD) is the most common progressive neurodegenerative
disease for which there is no cure. Recent studies have shown a close link between type 2 …

Alzheimer's disease (AD) and diabetes mellitus, especially type 2 (T2DM), are very common
and widespread diseases in contemporary societies, and their incidence is steadily on the …